Literature DB >> 10541590

PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma.

S Niemann1, D Steinberger, U Müller.   

Abstract

Paragangliomas (glomus tumors) are slowly growing, mostly benign tumors of the parasympathetic ganglia which most frequently occur in the head and neck region. Between 10% and 50% of cases are familial and follow an autosomal dominant mode of inheritance. The trait is maternally imprinted and exclusively transmitted through the paternal line. To date, two loci have been implicated in this disorder: one at 11q23 (PGL1), the other one at 11q13 (PGL2). We have analyzed a large German family with hereditary paraganglioma, but no evidence of maternal imprinting. By linkage analysis with markers flanking both PGL1 and PGL2, we demonstrate that the trait does not segregate with either of the loci at 11q. Our findings show that a third locus, PGL3, can be involved in hereditary paraganglioma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541590     DOI: 10.1007/s100480050078

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  10 in total

Review 1.  Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.

Authors:  P Björklund; K Pacak; J Crona
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 2.  SDHC mutations in hereditary paraganglioma/pheochromocytoma.

Authors:  Ulrich Müller; Christian Troidl; Stephan Niemann
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Hereditary paragangliomas.

Authors:  Margarita Raygada; Barbara Pasini; Constantine A Stratakis
Journal:  Adv Otorhinolaryngol       Date:  2011-02-24

Review 4.  Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.

Authors:  Aikseng Ooi
Journal:  Semin Cancer Biol       Date:  2019-11-02       Impact factor: 15.707

Review 5.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

6.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

Review 7.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

8.  Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC.

Authors:  Stephan Niemann; Ulrich Müller; Dieter Engelhardt; Peter Lohse
Journal:  Hum Genet       Date:  2003-03-25       Impact factor: 4.132

Review 9.  The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Authors:  Brian Shuch; Christopher J Ricketts; Adam R Metwalli; Karel Pacak; W Marston Linehan
Journal:  Urology       Date:  2014-03-15       Impact factor: 2.649

Review 10.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.